Jade Biosciences, Inc. Common Stock
$16.94
-$0.20 (-1.17%)
$16.79Day Range$17.35
Key Statistics
Market Cap
$1.08B
Shares Outstanding
63.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 29, 2025
Round Lot
100
Locale
US
Trading Data
Day Open
$17.15
Day High
$17.35
Day Low
$16.79
Volume
2.94M
VWAP
$16.98
Prev Close
$17.14
Transactions
--
Acc. Volume
--
About Jade Biosciences, Inc. Common Stock
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
PHARMACEUTICAL PREPARATIONSSIC 283455 employees221 CRESCENT ST., WALTHAM, MA, 02453(781) 312-3013IPO Apr 29, 2025US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001798749
- Composite FIGI
- BBG00WGHZFH4
- Share Class FIGI
- BBG00WGHZFJ2
- Ticker Root
- JBIO
- SIC Code
- 2834
About Jade Biosciences, Inc. Common Stock (JBIO) Stock
Jade Biosciences, Inc. Common Stock (JBIO) closed the 2026-09-18 session at $16.94, down 1.17% versus the previous close (-0.20). The stock opened at $17.15 and traded between $16.79 and $17.35 during that session. Session trading volume was 2.9M shares. The volume-weighted average price (VWAP) is $16.98.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Jade Biosciences, Inc. Common Stock has a market capitalization of $1.08 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. JBIO is listed on the XNAS exchange. The company employs approximately 55 people. Jade Biosciences, Inc. Common Stock is headquartered in WALTHAM, MA. The recorded listing date is 2025-04-29.
On this page you can find market JBIO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.